Get the Stockscreener App
283.88
1.39%
3.88
Pre-market:
282.89
-0.99
-0.35%
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $283.88, with a volume of 716.64K.
It is up +1.39% in the last 24 hours and up +10.52% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$280.00
Open:
$280.48
24h Volume:
716.64K
Relative Volume:
1.10
Market Cap:
$23.28B
Revenue:
$14.14B
Net Income/Loss:
$942.70M
P/E Ratio:
25.15
EPS:
11.2856
Net Cash Flow:
$1.38B
1W Performance:
+7.05%
1M Performance:
+10.52%
6M Performance:
+13.15%
1Y Performance:
+7.42%
1-Day Range:
$278.70
$286.55
1-Week Range:
$264.11
$286.55
52-Week Range:
$241.81
$293.72
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
283.88 | 22.96B | 14.14B | 942.70M | 1.38B | 11.29 |
TMO
Thermo Fisher Scientific Inc
|
513.33 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.72 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
537.58 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
276.27 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.39 | 37.52B | 7.23B | 1.41B | 1.09B | 4.979 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Form 144 LABCORP HOLDINGS INC. For: 1 July By Investing.com - Investing.com South Africa
LH (LH) Form 144: insider sale notice for 7,138 shares - Stock Titan
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 - BioSpace
Labcorp Holdings Inc. (LH) Announces Upcoming Release of Q2 2026 Financial Results - GuruFocus
Labcorp to report Q2 2026 results July 30; webcast at 9:00 a.m. ET - TradingView
Labcorp (NYSE: LH) sets July 30, 2026 Q2 earnings webcast - Stock Titan
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp extends ColoSense rollout, shares trade steadily on Xetra - Ad-hoc-news.de
Price to earnings forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Price to earnings forward of Labcorp Holdings Inc. – SWB:N6B - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – SWB:N6B - TradingView
Price to earnings forward of Labcorp Holdings Inc. – BIVA:LH - TradingView
Why Labcorp (LH) Is Up 6.1% After FDA Approval, Medicare Coverage Of ColoSense At-Home Test - Yahoo Finance
Price to sales forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Price to sales forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is Labcorp Holdings stock underperforming the Nasdaq? - MSN
Enterprise value to EBITDA forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Labcorp Holdings (LH) Could Be 14% Undervalued As Growth Narrative Builds - Sahm
Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh - TradingView
Price to earnings forward of Labcorp Holdings Inc. – BOATS:LH - TradingView
Enterprise value to EBIT forward of Labcorp Holdings Inc. – NYSE:LH - TradingView
Enterprise value to revenue forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Price to book forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Enterprise value to EBIT forward of Labcorp Holdings Inc. – LSX:A40C39 - TradingView
Labcorp Holdings Inc. Actuals & Estimates (NYSE:LH) - TradingView
LH Forecast — Price Target — Prediction for 2027 - TradingView
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks - Yahoo Finance
Is it the Right Time to Add Labcorp Stock to Your Portfolio? - Yahoo Finance
Labcorp Holdings Inc (LH) Institutional Confidence - TradingKey
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Husch Blackwell Assists LabCorp in Securing Texas Supreme Court Victory in Medicaid Fraud Statute Case - Husch Blackwell
Labcorp Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Test - Sahm
Labcorp Announces Nationwide Availability of ColoSense®, the Fir - GuruFocus
Labcorp (LH) Launches ColoSense, an Innovative Colorectal Cancer Screening Test - GuruFocus
Labcorp launches FDA-approved at-home colorectal cancer test By Investing.com - Investing.com Canada
Labcorp brings at-home colorectal cancer test to all 50 states - Stock Titan
LHLabcorp Holdings Inc Options - Finviz
Labcorp Holdings Inc (LH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
$35M Labcorp data breach class action settlement - Class Action Lawsuits
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is Labcorp Holdings Stock Underperforming the Nasdaq? - Yahoo Finance
Labcorp Holdings Inc (LH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Labcorp Holdings Inc (LH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Labcorp Holdings Inc (LH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Labcorp Holdings Inc (LH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Labcorp Holdings Inc (LH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Labcorp Holdings Inc (LH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Labcorp Holdings Inc (LH) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):